Divalproex Sodium Tablet, Delayed Release
Product Images NDC 0904-6861

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0904-6861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F0a664b1 B47c 49e8 Bba4 754bb4e2c182 00

This is a description of a unit dose bottle of Divalproex Sodium delayed-release tablets made by the company Major. It includes the National Drug Code (NDC) for tracking and dispensing, information about the usual dosage and reasons for use, and a warning that it should only be dispensed with a Medication Guide and under the supervision of a pharmacist.*

FDA Label Image

Carton Label (Image 01)

This is a description for Divalproex Sodium Delayed-Release Tablets in unit dose packaging. The dosage and instructions for use are not available. It seems to be a product by Major and provided in an airtight container.*

FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

This appears to be a graph with x and y axes. The x-axis seems to show the percentage of patients while the y-axis shows the reduction in CPS rate in percentage. The graph also seems to show two lines, one representing a drug (DVPX) and the other a placebo. The graph is labeled as Figure 2. No further information can be obtained from this text.*

FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

The text is a description of a figure showing the mean 4-week Migraine Rates for Placebo and DVPX in Study 1 and Study 2. There are two groups: Placebo and DVPX, and two studies have been conducted: Study 1 and Study 2. However, the specifics of the actual rates are not available.*

FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.